258 related articles for article (PubMed ID: 32071059)
21. Radicicol confers mid-schizont arrest by inhibiting mitochondrial replication in Plasmodium falciparum.
Chalapareddy S; Bhattacharyya MK; Mishra S; Bhattacharyya S
Antimicrob Agents Chemother; 2014 Aug; 58(8):4341-52. PubMed ID: 24841259
[TBL] [Abstract][Full Text] [Related]
22. Stage specific activity of synthetic antimalarial endoperoxides, N-89 and N-251, against Plasmodium falciparum.
Morita M; Koyama T; Sanai H; Sato A; Hiramoto A; Masuyama A; Nojima M; Wataya Y; Kim HS
Parasitol Int; 2015 Feb; 64(1):113-7. PubMed ID: 25449979
[TBL] [Abstract][Full Text] [Related]
23. In Vivo and In Vitro Optimization of Screening Antimalarial Hits toward Lead Molecules for Preclinical Development.
Fröhlich T; Tsogoeva SB
J Med Chem; 2016 Nov; 59(21):9668-9671. PubMed ID: 27775354
[TBL] [Abstract][Full Text] [Related]
24. Optimal assay design for determining the in vitro sensitivity of ring stage Plasmodium falciparum to artemisinins.
Xie SC; Dogovski C; Kenny S; Tilley L; Klonis N
Int J Parasitol; 2014 Oct; 44(12):893-9. PubMed ID: 25161101
[TBL] [Abstract][Full Text] [Related]
25. Identification of
Wang X; Miyazaki Y; Inaoka DK; Hartuti ED; Watanabe YI; Shiba T; Harada S; Saimoto H; Burrows JN; Benito FJG; Nozaki T; Kita K
Genes (Basel); 2019 Jun; 10(6):. PubMed ID: 31234346
[TBL] [Abstract][Full Text] [Related]
26. Blockage of spontaneous Ca2+ oscillation causes cell death in intraerythrocitic Plasmodium falciparum.
Enomoto M; Kawazu S; Kawai S; Furuyama W; Ikegami T; Watanabe J; Mikoshiba K
PLoS One; 2012; 7(7):e39499. PubMed ID: 22792177
[TBL] [Abstract][Full Text] [Related]
27. Lactate retards the development of erythrocytic stages of the human malaria parasite Plasmodium falciparum.
Hikosaka K; Hirai M; Komatsuya K; Ono Y; Kita K
Parasitol Int; 2015 Jun; 64(3):301-3. PubMed ID: 25176135
[TBL] [Abstract][Full Text] [Related]
28. A simple and predictive phenotypic High Content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds.
Lucantoni L; Silvestrini F; Signore M; Siciliano G; Eldering M; Dechering KJ; Avery VM; Alano P
Sci Rep; 2015 Nov; 5():16414. PubMed ID: 26553647
[TBL] [Abstract][Full Text] [Related]
29. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
[TBL] [Abstract][Full Text] [Related]
30. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit
Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH
ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii.
Varberg JM; LaFavers KA; Arrizabalaga G; Sullivan WJ
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158278
[TBL] [Abstract][Full Text] [Related]
32. Screening the Pathogen Box for Inhibition of Plasmodium falciparum Sporozoite Motility Reveals a Critical Role for Kinases in Transmission Stages.
Kanatani S; Elahi R; Kanchanabhogin S; Vartak N; Tripathi AK; Prigge ST; Sinnis P
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0041822. PubMed ID: 35943271
[TBL] [Abstract][Full Text] [Related]
33. A novel approach for the discovery of chemically diverse anti-malarial compounds targeting the Plasmodium falciparum Coenzyme A synthesis pathway.
Fletcher S; Avery VM
Malar J; 2014 Aug; 13():343. PubMed ID: 25174342
[TBL] [Abstract][Full Text] [Related]
34. Structure activity refinement of phenylsulfonyl piperazines as antimalarials that block erythrocytic invasion.
Nguyen W; Dans MG; Ngo A; Gancheva MR; Romeo O; Duffy S; de Koning-Ward TF; Lowes KN; Sabroux HJ; Avery VM; Wilson DW; Gilson PR; Sleebs BE
Eur J Med Chem; 2021 Mar; 214():113253. PubMed ID: 33610028
[TBL] [Abstract][Full Text] [Related]
35. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
36. In Vitro Evaluation of Two Novel Antimalarial Derivatives of SKM13: SKM13-MeO and SKM13-F.
Trinh TT; Kim YA; Hong H; Le LTT; Jang H; Kim SA; Park H; Kim HS; Yeo SJ
Korean J Parasitol; 2022 Dec; 60(6):401-407. PubMed ID: 36588416
[TBL] [Abstract][Full Text] [Related]
37. Yeast-based high-throughput screen identifies Plasmodium falciparum equilibrative nucleoside transporter 1 inhibitors that kill malaria parasites.
Frame IJ; Deniskin R; Rinderspacher A; Katz F; Deng SX; Moir RD; Adjalley SH; Coburn-Flynn O; Fidock DA; Willis IM; Landry DW; Akabas MH
ACS Chem Biol; 2015 Mar; 10(3):775-83. PubMed ID: 25602169
[TBL] [Abstract][Full Text] [Related]
38. Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as PfeEF2.
Laleu B; Rubiano K; Yeo T; Hallyburton I; Anderson M; Crespo-Fernandez B; Gamo FJ; Antonova-Koch Y; Orjuela-Sanchez P; Wittlin S; Jana GP; Maity BC; Chenu E; Duffy J; Sjö P; Waterson D; Winzeler E; Guantai E; Fidock DA; Hansson TG
ChemMedChem; 2022 Nov; 17(22):e202200393. PubMed ID: 36129427
[TBL] [Abstract][Full Text] [Related]
39. A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery.
Almela MJ; Lozano S; Lelièvre J; Colmenarejo G; Coterón JM; Rodrigues J; Gonzalez C; Herreros E
PLoS One; 2015; 10(8):e0135139. PubMed ID: 26317851
[TBL] [Abstract][Full Text] [Related]
40. Evaluating antimalarial efficacy by tracking glycolysis in Plasmodium falciparum using NMR spectroscopy.
Shivapurkar R; Hingamire T; Kulkarni AS; Rajamohanan PR; Reddy DS; Shanmugam D
Sci Rep; 2018 Dec; 8(1):18076. PubMed ID: 30584241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
